批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2022/11/17 |
SUPPL-38(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2016/08/12 |
SUPPL-36(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/08/07 |
SUPPL-35(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2014/04/30 |
SUPPL-34(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2013/10/16 |
SUPPL-33(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/04/05 |
SUPPL-31(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2013/04/02 |
SUPPL-32(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2012/01/20 |
SUPPL-29(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2010/12/17 |
SUPPL-30(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2010/05/25 |
SUPPL-28(补充) |
Approval |
Labeling |
UNKNOWN
|
|
|
2009/02/11 |
SUPPL-26(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2007/01/05 |
SUPPL-22(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2005/09/02 |
SUPPL-21(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2004/10/22 |
SUPPL-19(补充) |
Approval |
Efficacy |
STANDARD
|
|
|
2004/07/09 |
SUPPL-20(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2003/12/12 |
SUPPL-18(补充) |
Approval |
Efficacy |
PRIORITY
|
|
|
2002/03/08 |
SUPPL-13(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2002/02/27 |
SUPPL-14(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2002/02/21 |
SUPPL-12(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2001/12/19 |
SUPPL-11(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2001/12/19 |
SUPPL-10(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2001/11/12 |
SUPPL-9(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2001/06/25 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2001/01/29 |
SUPPL-6(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2001/01/09 |
SUPPL-5(补充) |
Approval |
Manufacturing (CMC) |
PRIORITY
|
|
|
2000/04/06 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2000/04/06 |
SUPPL-3(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1999/08/31 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
|
|
|
1999/04/23 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
PRIORITY
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)